Crinetics Pharmaceuticals Inc (CRNX) Ownership

56.07 ↑0.00 (0.00%)

As of December 31, 1969, 7:00pm EST.

Institutions
Mutual Funds

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Crinetics Pharmaceuticals Inc (CRNX), owning a total of 6.2 million shares. Combined, the top 36 institutional holders of CRNX own 96.11% of the company with a total of 78.5 million shares.

In the latest ownership report on June 30th 2024, the top 36 institutional holders increased their combined ownership of CRNX by 217 thousand shares. 9 institutions bought 6,258,937 total additional shares and increased their ownership by an average of 25.21%. However 11 institutions sold 6,042,372 total shares and decreased their ownership by an average of 20.09%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Crinetics Pharmaceuticals increased by a net total of 216,565 in the latest quarter.

Institution Ownership Chart

Latest Institutional Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
BlackRock Inc	6.920%	14.611%	6,230,371	794,267	2024-06-30
Driehaus Capital Management LLC	6.789%	16.950%	6,112,173	885,876	2024-06-30
Wellington Management Company LLP	5.132%	55.487%	4,620,413	1,648,831	2024-06-30
Vanguard Group Inc	5.014%	26.276%	4,514,478	939,402	2024-06-30
T. Rowe Price Associates, Inc.	4.894%	15.255%	4,406,456	583,238	2024-06-30
EcoR1 Capital, LLC	4.615%	0.000%	4,155,375	0	2024-06-30
FMR Inc	4.550%	-8.219%	4,096,795	-366,881	2024-06-30
State Street Corp	3.124%	-13.588%	2,812,923	-442,330	2024-06-30
Point72 Asset Management, L.P.	3.089%	-43.815%	2,780,856	-2,168,630	2024-06-30
Jennison Associates LLC	3.088%	-1.338%	2,780,144	-37,710	2024-06-30
Paradigm Biocapital Advisors LP	2.792%	-19.568%	2,513,302	-611,447	2024-06-30
HHG PLC	2.727%	24.138%	2,455,661	477,489	2024-06-30
Geode Capital Management, LLC	1.864%	19.765%	1,678,387	276,984	2024-06-30
Morgan Stanley - Brokerage Accounts	1.863%	36.986%	1,677,250	452,850	2024-06-30
Perceptive Advisors LLC	1.640%	0.000%	1,476,203	0	2024-06-30
Cormorant Asset Management, LLC	1.499%	17.391%	1,350,000	200,000	2024-06-30
T. Rowe Price Investment Management,Inc.	1.496%	-49.252%	1,347,210	-1,307,519	2024-06-30
Orbimed Advisors, LLC	1.423%	-7.524%	1,280,800	-104,200	2024-06-30
First Light Asset Management, LLC	1.333%	-28.972%	1,200,508	-489,669	2024-06-30
Artal Group S A	1.184%	-23.331%	1,066,064	-324,413	2024-06-30
Novo A/S	1.249%	-8.975%	1,000,000	-98,600	2024-06-30
Nuveen Asset Management, LLC	0.578%	-16.429%	462,766	-90,973	2024-06-30

Top Institutions

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
BlackRock Inc	6.920%	14.611%	6,230,371	794,267	2024-06-30
Driehaus Capital Management LLC	6.789%	16.950%	6,112,173	885,876	2024-06-30
Wellington Management Company LLP	5.132%	55.487%	4,620,413	1,648,831	2024-06-30
Vanguard Group Inc	5.014%	26.276%	4,514,478	939,402	2024-06-30
T. Rowe Price Associates, Inc.	4.894%	15.255%	4,406,456	583,238	2024-06-30
EcoR1 Capital, LLC	4.615%	0.000%	4,155,375	0	2024-06-30
FMR Inc	4.550%	-8.219%	4,096,795	-366,881	2024-06-30
State Street Corporation	4.067%	-8.656%	3,255,253	-308,483	2024-03-31
State Street Corp	3.124%	-13.588%	2,812,923	-442,330	2024-06-30
Point72 Asset Management, L.P.	3.089%	-43.815%	2,780,856	-2,168,630	2024-06-30
Jennison Associates LLC	3.088%	-1.338%	2,780,144	-37,710	2024-06-30
Bvf Inc	5.005%	0.000%	2,736,613	0	2023-03-31
Paradigm Biocapital Advisors LP	2.792%	-19.568%	2,513,302	-611,447	2024-06-30
HHG PLC	2.727%	24.138%	2,455,661	477,489	2024-06-30
BRAIDWELL LP	3.694%	-41.790%	2,019,714	-1,449,960	2023-03-31
Geode Capital Management, LLC	1.864%	19.765%	1,678,387	276,984	2024-06-30
Morgan Stanley - Brokerage Accounts	1.863%	36.986%	1,677,250	452,850	2024-06-30
Perceptive Advisors LLC	1.640%	0.000%	1,476,203	0	2024-06-30
Cormorant Asset Management, LLC	1.499%	17.391%	1,350,000	200,000	2024-06-30
T. Rowe Price Investment Management,Inc.	1.496%	-49.252%	1,347,210	-1,307,519	2024-06-30
Goldman Sachs Group Inc	1.651%	135.315%	1,300,346	747,748	2023-12-31
Orbimed Advisors, LLC	1.423%	-7.524%	1,280,800	-104,200	2024-06-30
Bain Capital Life Sciences Investors, LLC	1.910%	-44.675%	1,275,552	-1,030,006	2023-09-30
First Light Asset Management, LLC	1.333%	-28.972%	1,200,508	-489,669	2024-06-30
Suvretta Capital Management, LLC	2.091%	0.000%	1,125,112	1,125,112	2022-06-30
Artal Group S A	1.184%	-23.331%	1,066,064	-324,413	2024-06-30
Eventide Asset Management, LLC	1.346%	0.000%	1,059,633	0	2024-03-31
Deep Track Capital, LP	1.943%	-0.396%	1,048,829	-4,171	2022-12-31
Novo A/S	1.249%	-8.975%	1,000,000	-98,600	2024-06-30
5AM Venture Management, LLC	1.291%	0.000%	862,286	0	2023-06-30
Opaleye Management Inc	1.265%	7.535%	845,000	59,206	2023-06-30
Finepoint Capital LP	1.458%	-8.164%	797,527	-70,900	2023-06-30
Saturn V Capital Management LLC	1.000%	-30.131%	787,132	-339,447	2023-12-31
Baker Bros Advisors LP	1.367%	-11.090%	735,716	-91,764	2022-09-30
Sphera Funds Management Ltd.	1.164%	6.771%	626,552	39,732	2022-09-30
Nuveen Asset Management, LLC	0.578%	-16.429%	462,766	-90,973	2024-06-30

Mutual Fund Ownership

Vanguard Total Stock Mkt Idx Inv is the biggest individual fund holder of Crinetics Pharmaceuticals Inc (CRNX), owning a total of 2.4 million shares. Combined, the top 47 mutual fund holders of CRNX own 46.00% of the company with a total of 36.5 million shares.

In the latest ownership report on October 31st 2024, the top 47 fund holders increased their combined ownership of CRNX by 51 thousand shares. 2 funds bought 71,441 total additional shares and increased their ownership by an average of 6.37%. However 2 funds sold 20,188 total shares and decreased their ownership by an average of 0.82%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Crinetics Pharmaceuticals increased by a net total of 51,253 in the latest report.

Mutual Funds Chart

Latest Mutual Fund Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
iShares Russell 2000 ETF	2.505%	-0.224%	2,255,048	-5,068	2024-10-31
SPDR® S&P Biotech ETF	1.164%	-1.423%	1,047,744	-15,120	2024-10-31
Bridge Builder Small/Mid Cap Growth	1.108%	0.801%	997,152	7,925	2024-10-31
iShares Russell 2000 Growth ETF	0.868%	0.000%	781,698	0	2024-10-31
iShares Biotechnology ETF	0.662%	11.934%	595,767	63,516	2024-10-31

Top Mutual Funds

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Vanguard Total Stock Mkt Idx Inv	2.668%	0.102%	2,402,086	2,446	2024-09-30
iShares Russell 2000 ETF	2.505%	-0.224%	2,255,048	-5,068	2024-10-31
US Small-Cap Growth II Equity Comp	2.245%	17.329%	2,020,841	298,470	2024-09-30
T. Rowe Price New Horizons	2.245%	-0.314%	2,020,841	-6,368	2024-09-30
Vanguard Instl Ttl Stck Mkt Idx Tr	2.409%	19.057%	1,609,013	257,544	2023-03-31
Fidelity® Select Biotechnology	1.846%	-9.960%	1,233,050	-136,400	2023-11-30
Vanguard Institutional Extnd Mkt Idx Tr	1.329%	13.079%	1,196,959	138,441	2024-09-30
T. Rowe Price Health Sciences	1.200%	1.815%	1,080,200	19,259	2024-09-30
SPDR® S&P Biotech ETF	1.164%	-1.423%	1,047,744	-15,120	2024-10-31
Fidelity Select Biotechnology	1.138%	-2.762%	1,024,650	-29,100	2024-09-30
Bridge Builder Small/Mid Cap Growth	1.108%	0.801%	997,152	7,925	2024-10-31
Vanguard Health Care Inv	1.066%	0.000%	960,171	0	2024-09-30
Vanguard Small Cap Index	1.058%	0.000%	952,975	952,975	2024-09-30
PGIM Jennison Health Sciences Z	0.920%	0.000%	827,891	0	2024-09-30
Jennison Health Sciences Equity	0.920%	0.000%	827,891	0	2024-09-30
Fidelity Small Cap Index	0.885%	-2.482%	796,760	-20,275	2024-08-31
iShares Russell 2000 Growth ETF	0.868%	0.000%	781,698	0	2024-10-31
MEDICAL BioHealth EUR Acc	0.867%	53.339%	780,122	271,367	2024-07-31
Eventide Healthcare & Life Sciences I	0.816%	-30.628%	735,088	-324,545	2024-06-30
Fidelity® Small Cap Index	0.932%	2.767%	622,829	16,771	2023-10-31
Vanguard Extended Market Index Investor	1.134%	-0.028%	619,920	-174	2023-08-31
iShares Biotechnology ETF	0.662%	11.934%	595,767	63,516	2024-10-31
Destinations Multi Strategy Alts I	1.082%	0.000%	591,805	0	2023-08-31
Fidelity Advisor® Biotechnology I	0.863%	15.762%	576,300	78,469	2023-11-30
Fidelity Advisor Biotechnology I	0.740%	0.000%	576,300	0	2024-02-29
T. Rowe Price US Small-Cap Core Equity	0.719%	-34.622%	575,542	-304,790	2024-06-30
T. Rowe Price Small-Cap Stock	0.719%	-34.622%	575,542	-304,790	2024-06-30
T. Rowe Price Integrated US SmCapGrEq	0.621%	1.611%	559,253	8,866	2024-09-30
T. Rowe Price Integrated US Sm Gr Eq	0.621%	-2.501%	559,253	-14,343	2024-09-30
Jennison SMid Cap Core Equity	0.620%	0.000%	557,911	0	2024-09-30
PGIM Jennison Small Company A	0.697%	0.000%	557,911	0	2024-09-30
Heptagon Driehaus US Micro Cap Eq C$ Acc	0.679%	-0.839%	535,427	-4,532	2024-05-31
Fidelity® Small Cap Value	0.749%	0.000%	500,000	500,000	2023-10-31
Fidelity Small Cap Value Fund	0.634%	0.000%	500,000	0	2024-03-31
iShares Russell 2000 Value ETF	0.634%	-0.132%	499,601	-662	2024-05-30
Fidelity Small Cap Growth	0.624%	-0.356%	491,780	-1,757	2024-04-30
BNP Paribas Health Cr Innovtr Cl Cap	0.654%	0.015%	436,676	64	2023-11-30
Fidelity® Series Large Cap Stock	0.724%	0.000%	389,800	0	2022-12-31
T. Rowe Price U.S. SC Core Eq Tr-Z	0.556%	60.132%	371,235	139,405	2023-09-30
State St Russell Sm/Mid Cp® Indx NL Cl C	0.661%	32.504%	361,186	88,600	2023-09-30
Wellington Global Hlthcr Eq USD G Ac	0.626%	-3.463%	342,476	-12,285	2023-08-31
Driehaus Event Driven	0.594%	0.000%	324,621	0	2023-07-31
USAA Science & Technology	0.477%	-5.082%	256,608	-13,738	2022-09-30
Heptagon Driehaus US Sm Cp Eq X1 USD Acc	0.459%	4.473%	247,866	10,613	2023-03-31
Destinations Small-Mid Cap Equity I	0.444%	-1.683%	239,905	-4,107	2023-04-30
Fidelity® Extended Market Index	0.419%	0.000%	226,004	0	2023-02-28
Driehaus Small Cap Growth Institutional	0.403%	-2.529%	216,645	-5,622	2022-11-30